...
首页> 外文期刊>Applied radiation and isotopes: including data, instrumentation and methods for use in agriculture, industry and medicine >Improved small scale production of iodine-124 for radiolabeling and clinical applications
【24h】

Improved small scale production of iodine-124 for radiolabeling and clinical applications

机译:改善碘-124的小规模生产用于放射性标记和临床应用

获取原文
获取原文并翻译 | 示例
           

摘要

AimThis work describes a small-scale production of iodine-124 using a 16.5?MeV cyclotron, and a subsequent validation of the formulated sodium [124I]iodide solution for routinely clinical applications. MethodsIodine-124 (124I) was produced via the124Te(p, n)124I reaction using a 16.5?MeV GE PETtrace? cyclotron. Irradiation was performed with a pre-prepared solid target consisting of [124Te]TeO2(99.93%) and Al2O3. Different layer thicknesses, irradiation and extraction parameters were tested. After irradiation at the cyclotron, the shuttle with irradiated material was transferred fully automatically via a tube system to the Comecer ALCEO?Halogen 2.0 extraction unit. Iodine-124 was subsequently extracted in form of sodium [124I]iodide ([124I]NaI) in 0.05?N aqueous NaOH solution, followed by reconstitution and validation for preclinical and clinical uses. ResultsGood result was achieved using a beam degradation foil of 500?μm thickness in combination with beam currents between 10 and 15?μA. Under these conditions, up to 150 MBq no-carrier-added [124I]NaI was obtained after a 2?h irradiation time in less than 500?μl 0.05?N NaOH. Isolation of [124I]NaI, including evaporation and extraction at the ALCEO?Halogen EVP unit was accomplished in 90?min 24?h after production (irradiation), the amount of iodine-123 as assessed by gamma-ray spectroscopy was less than 1.5%. The undesirable iodine-125 was not detectable by gamma spectroscopy. The extracted [124I]NaI could be used directly for radiolabeling purposes, and after buffering with phosphate buffered saline (PBS) and sterile filtration for clinical applications. ConclusionsThrough the optimized conditions for irradiation and extraction, iodine-124 was produced in good radiochemical yields and high radionuclide purity. The generated injectable [124I]NaI solution was sterile, non-pyrogenic and ready for preclinical and clinical applications after a sterile filtration through a 0.22?μm membrane filter.
机译:AIMTHIS工作描述了使用16.5〜MEV回旋加速器的碘-124的小规模生产,以及随后对制备的钠[124i]碘化物溶液进行常规临床应用的验证。使用16.5μl24i反应产生的方法碘-124(124i)由16.5μl24i反应产生?回旋加速器。用预制备的固体靶靶制,由[124tH] TEO 2(99.93%)和Al 2 O 3组成。测试了不同的层厚度,照射和提取参数。在回旋加速器照射后,通过管系统将带有照射材料的梭子自动转移到Comecer Alceo?卤素2.0提取单元。随后以0.05·Nα水溶液([124I]碘化钠([124i]碘化物)的形式提取碘-124,然后重构和验证临床前和临床用途。使用500Ωμm厚度的光束劣化箔与横梁电流组合在10和15Ωa之间实现的结果,实现了结果。在这些条件下,在少于500μl0.05≤nnaoh的2℃照射时间后获得高达150mbq无载体添加的[124i] nai。 [124i] Nai的分离,包括在Alceo的蒸发和提取物中的蒸发和萃取物在生产(辐照)后90?最小24Ωh,通过γ射线光谱评估的碘-123的量小于1.5 %。 γ光谱法不可检测不希望的碘-125。提取的[124i] nai可以直接用于放射性标记目的,并在缓冲后,用磷酸盐缓冲盐水(PBS)和临床应用的无菌过滤。结论碘-124良好放射化学产率和高放射性核素纯度生产的优化条件。产生的注射剂[124i] Nai溶液是无菌的,非热原性的,并且在通过0.22Ω膜过滤器的无菌过滤后准备临床前和临床应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号